Funder
World Bank African Centers of Excellence grant
Wellcome Trust DELTAS grant
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference33 articles.
1. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg. 2001;64:28–35.
2. WHO. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville: World Health Organization, 2004. http// www.who.int/malaria/publications/atoz/afr_mal_04_01/en . Accessed 19 May 2016.
3. WHO. Updated WHO Policy Recommendation (October 2012): Intermittent Preventative Treatment of Malaria in Pregnancy Using Sulfadoxine–Pyrimethamine (IPTp-SP). Geneva: World Health Organization. http// www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf . Accessed 19 May 2016.
4. Diakite OS, Kayentao K, Traoré BT, Djimde A, Traoré B, Diallo M, et al. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. Clin Infect Dis. 2011;53:215–23.
5. Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, et al. Rapid increase in the prevalence of sulfadoxine–pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008;198:1545–9.